Noleus Technologies

Noleus Technologies is a Boston-based, privately-held medical device startup founded in 2017. The company is developing a novel medical device platform aimed at reducing fluid overload and tissue swelling to accelerate recovery after surgery, with an initial focus on post-operative ileus (POI) following abdominal procedures. It has garnered early validation through multiple accelerator participations and pitch competition awards. Noleus appears to be in the pre-revenue, pre-clinical or early development stage, building its technology and seeking funding.

Proprietary medical device platform designed to reduce post-surgical fluid overload and tissue swelling (edema) to accelerate patient recovery.

Competition may come from other medical device startups targeting surgical recovery, pharmacological approaches to managing POI (e.g., peripherally acting mu-opioid receptor antagonists), and the broader trend of Enhanced Recovery After Surgery (ERAS) protocols which bundle multiple interventions. Noleus's differentiation lies in its direct, physical approach to managing post-surgical edema.